HHLR Advisors’s Kiniksa Pharmaceuticals KNSA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $31.3M | Hold |
|
|||||
|
2024
Q3 | $39.6M | Sell |
|
|||||
|
2024
Q2 | $58.7M | Buy |
|
|||||
|
2024
Q1 | $61.9M | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $12.1M | Hold |
|
|||||
|
2023
Q2 | $9.84M | Sell |
|
|||||
|
2023
Q1 | $11M | Sell |
|
|||||
|
2022
Q4 | $39.3M | Sell |
|
|||||
|
2022
Q3 | $37.5M | Hold |
|
|||||
|
2022
Q2 | $28.3M | Hold |
|
|||||
|
2022
Q1 | $29M | Hold |
|
|||||
|
2021
Q4 | $34.4M | Hold |
|
|||||
|
2021
Q3 | $33.3M | Hold |
|
|||||
|
2021
Q2 | $40.7M | Hold |
|
|||||
|
2021
Q1 | $54M | Hold |
|
|||||
|
2020
Q4 | $51.6M | Hold |
|
|||||
|
2020
Q3 | $44.7M | Buy |
|
|||||
|
2020
Q2 | $62.3M | Buy |
|
|||||
|
2020
Q1 | $29.3M | Hold |
|
|||||
|
2019
Q4 | $21M | Buy |
|
|||||
|
2019
Q3 | $15.9M | Buy |
|
|||||
|
2019
Q2 | $24.9M | Hold |
|
|||||
|
2019
Q1 | $33.2M | Buy |
|
|||||
|
2018
Q4 | $39M | Buy |
|